Log In
BCIQ
Print this Print this
 

arhalofenate (MBX-102)

Also known as: metaglidasen (JNJ39659100)

  Manage Alerts
Collapse Summary General Information
Company CymaBay Therapeutics Inc.
DescriptionUricosuric agent
Molecular Target Solute carrier family 22 organic anion urate transporter member 12 (SLC22A12) (URAT1)
Mechanism of ActionInsulin sensitizer
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHyperuricemia / gout
Indication DetailsTreat gout; Treat hyperuricemia in gout patients
Regulatory Designation
PartnerKowa Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$205.0M

$5.0M

$200.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/03/2017

$205.0M

$5.0M

$200.0M

Get a free BioCentury trial today